Skip to main content
SpringerLink
Log in

OKT-3: is significantly better than conventional treatment for reversing renal allograft rejection

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

OKT-3: is significantly better than conventional treatment for reversing renal allograft rejection. Inpharma Wkly. 501, 6 (1985). https://doi.org/10.1007/BF03312389

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03312389

Keywords

Search

Navigation